Krzysztof Brzozka
Chief Tech/Sci/R&D Officer presso RYVU THERAPEUTICS S.A.
Patrimonio netto: 4 M $ in data 31/03/2024
Posizioni attive di Krzysztof Brzozka
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 17/07/2014 | - |
| Corporate Officer/Principal | 01/01/2007 | 17/07/2014 | |
Ardigen SA
 Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Director/Board Member | - | - |
Storia della carriera di Krzysztof Brzozka
Formazione di Krzysztof Brzozka
| Uniwersytet Jagiellonski | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| Cracow University of Economics | Masters Business Admin |
| Stockholm Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Polonia | 5 |
| Germania | 2 |
| Svezia | 2 |
Posizioni
| Masters Business Admin | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 5 |
| Health Technology | 2 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Aziende private | 1 |
|---|---|
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Technology Services |
- Borsa valori
- Insiders
- Krzysztof Brzozka
- Esperienza
